Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.By their very nature, these stocks carry above-average risk and volatility. Moreover, if a company's growth story is over or nearing its end, betting on it could lead to significant loss.However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Sco ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Boston Scientific (BSX) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Boston Scientific is a member of our Medical group, which includes 1018 different companies and currently sits at #3 in the Zacks Sector Rank. The Zacks Sector Rank include ...

The beginning of this month saw choppy trading sessions for equities, with the S&P 500 recording its worst day on Aug 5 since 2022. However, the S&P 500 bounced back last week after positive economic reports on retail sales and initial jobless claims quelled recession apprehensions. The broader index has now notched its eighth straight winning streak on Aug 19 for the first time in 2024.Hence, it is prudent for investors to place bets on profitable and not loss-making stocks of the S&P 500. These stocks are ...

Boston Scientific (BSX) recently elected to voluntarily withdraw and refile its Premerger Notification and Report Form (the “HSR Filing”) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), in connection with Boston Scientific’s proposed acquisition of Silk Road Medical.This voluntary withdrawal is intended to give the U.S. Federal Trade Commission (FTC) additional time to review the proposed transaction.More on the NewsIn June 2024, Boston Scientific announced that i ...

MARLBOROUGH, Mass., Aug. 13, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Wells Fargo's 2024 Healthcare Conference on Wednesday, September 4, 2024.Mike Mahoney, chairman and chief executive officer, and Dr. Brad Sutton, chief medical officer, Atrial Fibrillation Solutions, will participate in a 35-minute question-and-answer session with the host analyst at approximately 8:00 a.m. ET. A live webcast and replay of the session will be accessible at htts://investors.bostons ...

U.S. stock markets have rebounded from last week’s devastations. The Wall Street rally, which started in January 2023, saw a significant change in July 2024. The rally was predominantly driven by the technology sector. An unprecedented adoption of generative artificial intelligence (AI) technology globally was the prime factor.Companies that have extensive applications of AI in their final products have become multi-baggers in the past 18 months. Stock prices of some of these companies have skyrocketed 200- ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about Boston Scientific (BSX) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Boston Scientific currently has an average brokerage re ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, it's pretty easy to find cutting-edge growth stocks with the he ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 1-11083 BOSTON SCIENTIFIC CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-2695240 (State or other jurisdiction of incorporation or or ...

Boston Scientific Corporation (BSX) is gaining traction in the emerging markets. New regulatory approvals and accretive acquisitions bode well for long-term growth. The stock carries a Zacks Rank #2 (Buy) currently.Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States. In the last reported second quarter of 2024, despite geopolitical weaknesses, the emerging market registered sturdy growth, primarily banking on continued broad-based ...